Prostate Cancer Treatment and Research

Prostate cancer is driven largely by androgen receptor signaling, and modern treatment research focuses on understanding how cancer cells sustain that signaling even when hormone levels are suppressed — a phenomenon central to why many therapies eventually stop working. Genomic profiling has revealed a landscape of genetic mutations, gene fusions, and chromosomal translocations that help explain both disease progression and differential responses to drugs like second-generation antiandrogens. A pressing open question is how tumors acquire resistance to these agents at the molecular level, and researchers are actively investigating whether immunotherapy can fill the gap where hormone-based approaches fail. Clinical trials are currently testing combinations of these strategies while also refining biomarkers that could predict, earlier and more precisely, which patients will benefit from which treatments.

Works

145,794

Total citations

1,461,344

Keywords

Prostate CancerAndrogen ReceptorGenomic ProfilingHormone TherapyMetastatic Prostate CancerImmunotherapy